Potential toxicity.
Duggal
M S
MS
Curzon
M E J
ME
Balmer
R
R
Roberts
J
J
D017607:Aluminum Compounds / Q000627:therapeutic use; D017610:Calcium Compounds / Q000627:therapeutic use; D002648:Child; D003407:Creosote / Q000627:therapeutic use; D003442:Crowns; D019140:Dental Care for Children; D003785:Dental Pulp Capping / Q000379:methods; D004338:Drug Combinations; D064420:Drug-Related Side Effects and Adverse Reactions; D005290:Ferric Compounds / Q000627:therapeutic use; D005566:Formocresols / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009303:Nasopharyngeal Neoplasms / Q000139:chemically induced; D010087:Oxides / Q000627:therapeutic use; D011672:Pulpotomy / Q000379:methods*; D012387:Root Canal Filling Materials / Q000009:adverse effects / Q000627:therapeutic use*; D017640:Silicates / Q000627:therapeutic use
D017607:Aluminum Compounds; D017610:Calcium Compounds; D004338:Drug Combinations; D005290:Ferric Compounds; D005566:Formocresols; D010087:Oxides; D012387:Root Canal Filling Materials; D017640:Silicates; C086631:mineral trioxide aggregate; C024823:ferric sulfate; D003407:Creosote